PTC Therapeutics to Participate at Upcoming Investor Conferences

PTCT 11.04.2024

Full Press ReleaseSEC FilingsOur PTCT Tweets

About Gravity Analytica

Recent News

  • 01.13.2025 - PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • 01.13.2025 - 2025 J.P. Morgan Healthcare Conference
  • 01.13.2025 - PTC Therapeutics Provides Update on Commercial Performance and R&D Pipeline at 43rd Annual J.P. Morgan Healthcare Conference

Recent Filings

  • 01.13.2025 - 8-K Current report
  • 01.13.2025 - EX-99.1 EX-99.1
  • 01.10.2025 - 144 Report of proposed sale of securities

WARREN, N.J.,Nov. 4, 2024/PRNewswire/ --PTC Therapeutics, Inc.(NASDAQ: PTCT) today announced that the company will present a company overview at the following conferences:

UBS Global Healthcare ConferenceWednesday, Nov. 13at2:45 p.m. PST/5:45 p.m. EST

Jefferies London Healthcare ConferenceTuesday, Nov. 19at11:30 a.m. GMT/6:30 a.m. EST

Citi's 2024 Global Healthcare ConferenceTuesday, Dec. 3at2:30 p.m. EST

The presentations will be webcast live on the Events and Presentations page under the Investor section ofPTC Therapeutics'website athttps://ir.ptcbio.com/events-presentationsand will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection.

AboutPTC Therapeutics, Inc.PTC is a global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to children and adults living with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need. The company's strategy is to leverage its strong scientific expertise and global commercial infrastructure to maximize value for its patients and other stakeholders. To learn more about PTC, please visit us atwww.ptcbio.comand follow us on Facebook, on X (formerly Twitter), and on LinkedIn.

For More Information:

Investors:Investor Relations+1 (908) 912-9848ir@ptcbio.com

Media:Jeanine Clemente+1 (908) 912-9406jclemente@ptcbio.com

CisionView original content:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-at-upcoming-investor-conferences-302295727.html

SOURCEPTC Therapeutics, Inc.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com